BELLUS Health Inc. — Form D/A
BELLUS Health Inc. of LAVAL, A8, a company, filed a Form D amendment with the SEC on 2019-01-29. The offering totals $24.0M, of which $24.0M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2019-01-29
- Form: D/A
- Accession: 0001259942-19-000002
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $24.0M
- Amount sold: $24.0M
- Investors: 14
- Date of first sale: 2018-12-18
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-330261
Issuer
- Name: BELLUS Health Inc.
- CIK: 0001259942
- Entity type: Corporation
- Jurisdiction: CANADA (FEDERAL LEVEL)
- Address: 275 ARMAND-FRAPPIER BLVD., LAVAL, A8, H7V 4A7
- Phone: 450-680-4500
Officers, directors & promoters (12)
| Name | Role | Location |
|---|
| Francesco Bellini | Director | Laval, A8 |
| Roberto Bellini | Director | Laval, A8 |
| Youssef L Bennani | Director | Laval, A8 |
| Franklin L Berger | Director | Laval, A8 |
| Clarissa L Desjardins | Director | Laval, A8 |
| Chau Quang Khuong | Director | Laval, A8 |
| Pierre L Larochelle | Director | Laval, A8 |
| Joseph L Rus | Director | Laval, A8 |
| Roberto Bellini | Executive Officer | Laval, A8 |
| Francois Desjardins | Executive Officer | Laval, A8 |
| Denis Garceau | Executive Officer | Laval, A8 |
| Tony Matzouranis | Executive Officer | Laval, A8 |
Other filings by this issuer (2)
More